Hualan Biological Vaccine Inc - Class A

SZSE:301207 (China)   Class A
Â¥ 21.28 (-8.87%) Apr 26
14.90
P/B:
2.04
Market Cap:
Â¥ 12.77B ($ 1.76B)
Enterprise V:
Â¥ 10.83B ($ 1.49B)
Volume:
9.83M
Avg Vol (2M):
2.43M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Hualan Biological Vaccine Inc ( SZSE:301207 ) from 2022 to Apr 27 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Hualan Biological Vaccine stock (SZSE:301207) PE ratio as of Apr 27 2024 is 14.9. More Details

Hualan Biological Vaccine Inc (SZSE:301207) PE Ratio (TTM) Chart

To

Hualan Biological Vaccine Inc (SZSE:301207) PE Ratio (TTM) Historical Data

Total 533
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
Hualan Biological Vaccine PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-27 14.9 2024-02-22 17.0
2024-04-26 14.9 2024-02-21 16.8
2024-04-25 16.4 2024-02-20 16.6
2024-04-24 16.2 2024-02-19 16.6
2024-04-23 16.3 2024-02-08 16.5
2024-04-22 16.2 2024-02-07 16.2
2024-04-19 15.9 2024-02-06 15.6
2024-04-18 16.0 2024-02-05 14.2
2024-04-17 16.1 2024-02-02 14.7
2024-04-16 15.6 2024-02-01 15.4
2024-04-15 16.0 2024-01-31 15.3
2024-04-12 16.1 2024-01-30 16.0
2024-04-11 16.4 2024-01-29 16.4
2024-04-10 16.2 2024-01-26 16.9
2024-04-09 16.7 2024-01-25 17.1
2024-04-08 15.9 2024-01-24 16.7
2024-04-03 16.9 2024-01-23 16.1
2024-04-02 16.8 2024-01-22 16.0
2024-04-01 17.0 2024-01-19 16.9
2024-03-29 16.7 2024-01-18 17.1
2024-03-28 16.5 2024-01-17 17.2
2024-03-27 16.2 2024-01-16 17.7
2024-03-26 16.5 2024-01-15 18.0
2024-03-25 16.6 2024-01-12 18.0
2024-03-22 16.9 2024-01-11 18.3
2024-03-21 17.4 2024-01-10 18.1
2024-03-20 17.6 2024-01-09 18.1
2024-03-19 17.5 2024-01-08 18.0
2024-03-18 17.7 2024-01-05 18.4
2024-03-15 17.7 2024-01-04 18.9
2024-03-14 17.5 2024-01-03 19.2
2024-03-13 17.4 2024-01-02 19.3
2024-03-12 17.6 2023-12-29 19.5
2024-03-11 17.3 2023-12-28 19.3
2024-03-08 16.8 2023-12-27 25.4
2024-03-07 16.8 2023-12-26 25.4
2024-03-06 17.2 2023-12-25 25.7
2024-03-05 17.3 2023-12-22 25.8
2024-03-04 17.6 2023-12-21 26.2
2024-03-01 17.4 2023-12-20 26.4
2024-02-29 17.4 2023-12-19 26.7
2024-02-28 16.9 2023-12-18 27.2
2024-02-27 17.6 2023-12-15 27.0
2024-02-26 17.2 2023-12-14 27.5
2024-02-23 17.1 2023-12-13 27.4

Hualan Biological Vaccine Inc (SZSE:301207) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Hualan Biological Vaccine Inc is engaged in Research, development, production and sales of human vaccines.